Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros

Base de dados
Intervalo de ano de publicação
1.
Oncology ; 81(2): 91-7, 2011.
Artigo em Inglês | MEDLINE | ID: mdl-21968290

RESUMO

OBJECTIVES: It was the aim of this study to evaluate clinicopathological characteristics and prognostic factors of uterine leiomyosarcomas (LMS). METHODS: Twenty-eight patients with uterine LMS were evaluated in this retrospective study. Their features and survival were analyzed by Kaplan-Meier and log-rank tests. RESULTS: The median age of the patients was 52 years (range 25-74). Nine patients had a disease with a mitotic count <10/10 high-power fields. Twenty-one patients presented with stage I disease, 1 with stage II and 6 with stage IV. Twelve patients underwent total hysterectomy and bilateral salpingo-oophorectomy, 2 simple hysterectomy, 5 myomectomy and 9 more comprehensive surgical treatments. Adjuvant chemotherapy was administered to 16 patients, whereas chemoradiation was given only to 2 patients. Fifty percent presented with recurrence of the disease. The median overall survival was 46 months. Age, mitotic count, type of surgery, adjuvant therapy, recurrence and clinical response to chemotherapy were not found to affect survival, while the menopausal status and FIGO (International Federation of Gynecology and Obstetrics) stage were found to be prognostic factors. CONCLUSION: In our series, the menopausal state and FIGO stage were found to be prognostic factors related to survival.


Assuntos
Leiomiossarcoma/mortalidade , Neoplasias Uterinas/mortalidade , Adulto , Idoso , Feminino , Humanos , Leiomiossarcoma/patologia , Leiomiossarcoma/terapia , Pessoa de Meia-Idade , Recidiva Local de Neoplasia/terapia , Estadiamento de Neoplasias , Prognóstico , Receptores de Estrogênio/análise , Resultado do Tratamento , Neoplasias Uterinas/patologia , Neoplasias Uterinas/terapia
2.
Eur J Cancer Care (Engl) ; 19(4): 548-50, 2010 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-19694800

RESUMO

Although uterine prolapse and carcinoma of the uterine cervix are not rare event, their association is very uncommon. An 86-year-old patient gravida 8, para 5 was admitted for vaginal bleeding from a uterine prolapse of 20 years of duration. On physical examination, a complete third-degree prolapsed uterus with an ulcerated lesion of 12 cm in maximum diameter involving both the anterior and posterior lips of the cervix was observed. Because of the poor performance status and high American Society of Anesthesiology scoring, the patient was admitted for a vaginal hysterectomy with upper vaginectomy in spinal anesthesia. However, she died of pulmonary embolism 20 days after surgery. A case of a cervical cancer with a complete uterine prolapse of 20 years of duration is reported. We believe that this case typically rare to see in a developed country might be a useful addition to the few published reports.


Assuntos
Histerectomia Vaginal , Neoplasias do Colo do Útero/complicações , Prolapso Uterino/complicações , Idoso de 80 Anos ou mais , Anticoagulantes/uso terapêutico , Feminino , Heparina/uso terapêutico , Humanos , Resultado do Tratamento
3.
Maturitas ; 41(2): 97-104, 2002 Feb 26.
Artigo em Inglês | MEDLINE | ID: mdl-11836040

RESUMO

OBJECTIVE: To assess beneficial effects of a soy rich diet on the main biomarkers of cardiovascular health in menopause, compared with the effects of the hormone replacement therapy (HRT). METHODS: 187 healthy asymptomatic postmenopausal women, aged 39-60, were recruited and randomized into three groups: a soy rich diet group, a HRT group, and a control group. Lipid profile, body mass index, blood pressure, endometrial thickness, uterine artery resistance index (RI), were evaluated in all the participants at the baseline, after 6 months, and at the end of the study. RESULTS: After a 6-month intervention period, the lipid profile in the soy rich diet group showed a favourable outcome, similar to that observed in the HRT group, but compliance to the diet was low. CONCLUSION: Soy products may be used in the prevention of cardiovascular risk in postmenopausal women because of their efficacy in contrasting the negative effects of menopause on the cardiovascular system, but our findings should be confirmed; moreover, suitable strategies to improve the compliance have to be considered.


Assuntos
Doenças Cardiovasculares/prevenção & controle , Dieta , Terapia de Reposição Hormonal , Lipoproteínas/sangue , Proteínas de Soja/administração & dosagem , Adulto , Apolipoproteínas/sangue , Pressão Sanguínea , Colesterol/sangue , HDL-Colesterol/sangue , LDL-Colesterol/sangue , Endométrio/patologia , Feminino , Humanos , Pessoa de Meia-Idade , Cooperação do Paciente , Pós-Menopausa , Triglicerídeos/sangue
4.
Ultrasound Obstet Gynecol ; 9(1): 49-52, 1997 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-9060131

RESUMO

The role of Doppler ultrasonography in the diagnosis of advanced cervical cancer continues to be controversial. This study was designed to assess the clinical value of the technique in terms of predicting the response to chemotherapy in patients with advanced cervical cancer. Twenty-three patients with cancer of the cervix (FIGO stages Ib bulky-IIIb) and 20 healthy women underwent transvaginal color Doppler assessment of the uterine arteries (both ascending and descending branches) and the intracervical vessels. Statistical analysis was performed by Student's t test for paired and unpaired data. The intracervical vessels were the only site to show significant differences both in the resistance and in velocity parameters. A subgroup of 14 patients, scheduled for neoadjuvant chemotherapy, were evaluated before and at the completion of treatment. A significant increase in resistance and pulsatility index values and a decrease in peak systolic velocity were observed in the ten patients who responded to chemotherapy. Preliminary results of our study suggest that Doppler parameters can be clinically useful in the evaluation of the response to neoadjuvant chemotherapy. More patients, sampled in a prospective way in order to increase the number of non-responders, would be necessary to assess the possible role of Doppler ultrasound in predicting which patients will respond to chemotherapy.


Assuntos
Ultrassonografia Doppler em Cores , Neoplasias do Colo do Útero/tratamento farmacológico , Idoso , Velocidade do Fluxo Sanguíneo , Colo do Útero/irrigação sanguínea , Feminino , Humanos , Pessoa de Meia-Idade , Resultado do Tratamento , Neoplasias do Colo do Útero/irrigação sanguínea , Neoplasias do Colo do Útero/diagnóstico por imagem , Resistência Vascular
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA